rs9340973
Variant names: 
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_000125.4(ESR1):c.1097-95A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000895 in 1,417,048 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.0046   (  5   hom.,  cov: 31) 
 Exomes 𝑓:  0.00045   (  6   hom.  ) 
Consequence
 ESR1
NM_000125.4 intron
NM_000125.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.115  
Publications
0 publications found 
Genes affected
 ESR1  (HGNC:3467):  (estrogen receptor 1) This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020] 
ESR1 Gene-Disease associations (from GenCC):
- estrogen resistance syndromeInheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98). 
BP6
Variant 6-152011561-A-G is Benign according to our data. Variant chr6-152011561-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 1254013.Status of the report is criteria_provided_single_submitter, 1 stars. 
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.00461  AC: 701AN: 152198Hom.:  5  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
701
AN: 
152198
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.000449  AC: 568AN: 1264732Hom.:  6   AF XY:  0.000372  AC XY: 238AN XY: 639650 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
568
AN: 
1264732
Hom.: 
 AF XY: 
AC XY: 
238
AN XY: 
639650
show subpopulations 
African (AFR) 
 AF: 
AC: 
473
AN: 
29456
American (AMR) 
 AF: 
AC: 
35
AN: 
44280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
24812
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
38640
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
81698
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
51850
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
4882
European-Non Finnish (NFE) 
 AF: 
AC: 
10
AN: 
935444
Other (OTH) 
 AF: 
AC: 
48
AN: 
53670
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 29 
 58 
 88 
 117 
 146 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00460  AC: 700AN: 152316Hom.:  5  Cov.: 31 AF XY:  0.00450  AC XY: 335AN XY: 74468 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
700
AN: 
152316
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
335
AN XY: 
74468
show subpopulations 
African (AFR) 
 AF: 
AC: 
653
AN: 
41580
American (AMR) 
 AF: 
AC: 
36
AN: 
15292
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5174
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10624
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
68024
Other (OTH) 
 AF: 
AC: 
9
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.498 
Heterozygous variant carriers
 0 
 36 
 72 
 107 
 143 
 179 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1
AN: 
3478
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Nov 22, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.